KORU Medical Systems to Present at H.C. Wainwright BioConnect 2021 Conference
KORU Medical Systems (NASDAQ: KRMD) announced that CEO Don Pettigrew will present a company overview at the virtual H.C. Wainwright BioConnect 2021 Conference from January 11-14, 2021. The presentation will be accessible on the investors' section of their website. KORU Medical specializes in developing and commercializing innovative infusion solutions aimed at enhancing the quality of life for patients globally. Their product line includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, among others, designed for home and alternate care settings.
- None.
- None.
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that Don Pettigrew, President and Chief Executive Officer, will provide a company overview at the H.C. Wainwright BioConnect 2021 Conference, held virtually from January 11-14, 2021. A copy of the presentation will be available on the “Investors” section of the Company’s website www.korumedical.com.
About KORU Medical Systems
KORU Medical Systems develops, manufactures, and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210111005609/en/
FAQ
When is the KORU Medical presentation at the H.C. Wainwright BioConnect 2021 Conference?
Who will represent KORU Medical at the conference?
Where can I find the KORU Medical presentation?
What products does KORU Medical Systems offer?
What is the focus of KORU Medical's products?
